Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model

Oncolytic virotherapy represents a promising alternative for cancer treatment; however, viral delivery to the tumor represents a major challenge. Mesenchymal stem cells (MSCs) chemotax to tumors, and can serve as a viral delivery tool. Previously, we demonstrated antitumor therapeutic efficacy for m...

Descripción completa

Detalles Bibliográficos
Autores principales: Rincón, Esther, Cejalvo, Teresa, Kanojia, Deepak, Alfranca, Arantzazu, Rodríguez-Milla, Miguel Ángel, Hoyos, Raul Andrés Gil, Han, Yu, Zhang, Lingjiao, Alemany, Ramón, Lesniak, Maciej S., García-Castro, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542197/
https://www.ncbi.nlm.nih.gov/pubmed/28525366
http://dx.doi.org/10.18632/oncotarget.17557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542197/
https://www.ncbi.nlm.nih.gov/pubmed/28525366
http://dx.doi.org/10.18632/oncotarget.17557

Ejemplares similares